V. Tiffreau

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

Karim Wahbi, Rabah Ben Yaou, Estelle Gandjbakhch et al. · Circulation · 2019 · 245 citations · Full text

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study

Céline Dogan, Marie De Antonio, Dalil Hamroun et al. · PLoS ONE · 2016 · 145 citations · Full text

Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials

Véronique Humbertclaude, Dalil Hamroun, Kamel Bezzou et al. · European Journal of Paediatric Neurology · 2011 · 138 citations

Medicine, Respiratory Neurobiology, Physiology +11

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian, Jean‐Michel Vallat, Laurent Magy et al. · Orphanet Journal of Rare Diseases · 2014 · 124 citations · Full text

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

Guilhem Solé, Emmanuelle Salort‐Campana, Yann Péréon et al. · Revue Neurologique · 2020 · 84 citations · Full text

Neuromuscular Patients, Virus Epidemiology, Covid-19 Pandemic Outbreak +8